Cornercap Investment Counsel Inc Gilead Sciences, Inc. Transaction History

Cornercap Investment Counsel Inc

$329 Million
Q3 2024

A detailed history of Cornercap Investment Counsel Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 22,086 shares of GILD stock, worth $2.15 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

22,086

Previous 33,124 33.32%

Holding current value

$2.15 Million

Previous $2.27 Million 18.53%

% of portfolio

0.56%

Previous 0.38%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$66.59 - $83.99 $735,020 - $927,081	-11,038 Reduced 33.32%	22,086 $1.85 Million
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $380,478 - $439,102	6,025 Added 22.23%	33,124 $2.27 Million
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $16,606 - $20,251	-232 Reduced 0.85%	27,099 $1.99 Million
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $39,639 - $44,951	541 Added 2.02%	27,331 $2.21 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $31,572 - $34,446	427 Added 1.62%	26,790 $2.01 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $124,276 - $141,754	-1,635 Reduced 5.84%	26,363 $2.03 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $77,541 - $88,344	1,003 Added 3.72%	27,998 $2.32 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $68,552 - $98,417	1,100 Added 4.25%	26,995 $2.32 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $75,437 - $86,168	-1,267 Reduced 4.66%	25,895 $1.6 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $5,252 - $5,915	-91 Reduced 0.33%	27,162 $1.68 Million
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $40,022 - $50,152	-691 Reduced 2.47%	27,253 $1.62 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $215,661 - $244,779	-3,324 Reduced 10.63%	27,944 $2.03 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $11,101 - $11,976	-164 Reduced 0.52%	31,268 $2.18 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $158,738 - $173,444	-2,501 Reduced 7.37%	31,432 $2.16 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $2.04 Million - $2.32 Million	33,933 New	33,933 $2.19 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $2.12 Million - $2.42 Million	-37,480 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $344,282 - $432,875	5,544 Added 17.36%	37,480 $2.37 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $2.31 Million - $2.68 Million	31,936 New	31,936 $2.46 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $210,580 - $256,720	-2,891 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $3.98 Million - $4.67 Million	-55,959 Reduced 95.09%	2,891 $208,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $4.24 Million - $5.03 Million	58,850	58,850 $4.77 Million

Others Institutions Holding GILD

# of Institutions

1,963

Shares Held

995M

Call Options Held

10.5M

Put Options Held

9.86M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $122B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Account

Cornercap Investment Counsel Inc Gilead Sciences, Inc. Transaction History